ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR LEUKEMIA USING CAMPATH-1 MONOCLONAL-ANTIBODIES AND POSTTRANSPLANT ALLOIMMUNIZATION WITH DONOR LYMPHOCYTES

Podobne zapisy

• Engraftment of marrow allografts treated with Campath-1 monoclonal antibodies.
  od: Naparstek, E, i wsp.
  Wydane: (1999)
• T-cell-depleted allogeneic bone marrow transplantation for acute leukaemia using Campath-1 antibodies and post-transplant administration of donor's peripheral blood lymphocytes for prevention of relapse.
  od: Naparstek, E, i wsp.
  Wydane: (1995)
• CAMPATH-1 monoclonal antibodies in bone marrow transplantation.
  od: Hale, G, i wsp.
  Wydane: (1994)
• Elimination of graft versus host disease in matched allogeneic leukemic transplant recipients using CAMPATH-1.
  od: Slavin, S, i wsp.
  Wydane: (1985)
• Elimination of graft-versus-host disease by in-vitro depletion of alloreactive lymphocytes with a monoclonal rat anti-human lymphocyte antibody (CAMPATH-1).
  od: Waldmann, H, i wsp.
  Wydane: (1984)